Form 4 for OMDA Omada Health, Inc.
Accepted 2026-04-10 16:05:47 ET · period of report 2026-04-08 · accession 0001610717-26-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-10 16:05 | 2026-04-08 | OMDA | Shao Wei-Li | Pres | S - Sale | $12.71 | -2,829 | 328.9K | -0.9% | -$35.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-08 | S | D | 2,829 | $12.71 | 328,850 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by Wei-Li Shao on August 15, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $12.51 to $13.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |